MyMD Pharmaceuticals (MYMD) Competitors $1.33 -0.09 (-6.34%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends MYMD vs. FREQ, WENA, SNSE, IPA, AYTU, INDP, TSBX, ADXN, VINC, and KPRXShould you be buying MyMD Pharmaceuticals stock or one of its competitors? The main competitors of MyMD Pharmaceuticals include Frequency Therapeutics (FREQ), ANEW Medical (WENA), Sensei Biotherapeutics (SNSE), ImmunoPrecise Antibodies (IPA), Aytu BioPharma (AYTU), Indaptus Therapeutics (INDP), Turnstone Biologics (TSBX), Addex Therapeutics (ADXN), Vincerx Pharma (VINC), and Kiora Pharmaceuticals (KPRX). These companies are all part of the "medical" sector. MyMD Pharmaceuticals vs. Frequency Therapeutics ANEW Medical Sensei Biotherapeutics ImmunoPrecise Antibodies Aytu BioPharma Indaptus Therapeutics Turnstone Biologics Addex Therapeutics Vincerx Pharma Kiora Pharmaceuticals MyMD Pharmaceuticals (NASDAQ:MYMD) and Frequency Therapeutics (NASDAQ:FREQ) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, media sentiment, community ranking, institutional ownership, dividends, profitability and earnings. Which has stronger valuation & earnings, MYMD or FREQ? MyMD Pharmaceuticals has higher earnings, but lower revenue than Frequency Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMyMD PharmaceuticalsN/AN/A-$4MN/AN/AFrequency Therapeutics$14.07M0.78-$81.58M-$1.89-0.16 Which has more risk & volatility, MYMD or FREQ? MyMD Pharmaceuticals has a beta of 2.15, suggesting that its stock price is 115% more volatile than the S&P 500. Comparatively, Frequency Therapeutics has a beta of 0.84, suggesting that its stock price is 16% less volatile than the S&P 500. Do analysts prefer MYMD or FREQ? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MyMD Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AFrequency Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media refer more to MYMD or FREQ? In the previous week, Frequency Therapeutics had 6 more articles in the media than MyMD Pharmaceuticals. MarketBeat recorded 6 mentions for Frequency Therapeutics and 0 mentions for MyMD Pharmaceuticals. MyMD Pharmaceuticals' average media sentiment score of 0.00 equaled Frequency Therapeutics'average media sentiment score. Company Overall Sentiment MyMD Pharmaceuticals Neutral Frequency Therapeutics Neutral Is MYMD or FREQ more profitable? Frequency Therapeutics' return on equity of -107.67% beat MyMD Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets MyMD PharmaceuticalsN/A -179.05% -108.14% Frequency Therapeutics N/A -107.67%-61.40% Does the MarketBeat Community believe in MYMD or FREQ? Frequency Therapeutics received 59 more outperform votes than MyMD Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformMyMD PharmaceuticalsN/AN/AFrequency TherapeuticsOutperform Votes5960.20% Underperform Votes3939.80% Do institutionals & insiders have more ownership in MYMD or FREQ? 9.6% of MyMD Pharmaceuticals shares are held by institutional investors. Comparatively, 13.2% of Frequency Therapeutics shares are held by institutional investors. 2.1% of MyMD Pharmaceuticals shares are held by company insiders. Comparatively, 16.8% of Frequency Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. SummaryFrequency Therapeutics beats MyMD Pharmaceuticals on 7 of the 9 factors compared between the two stocks. Ad Porter & CompanyNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again. Here’s the full story for you. Get MyMD Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MYMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MYMD vs. The Competition Export to ExcelMetricMyMD PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.15M$2.31B$5.40B$8.53BDividend YieldN/A0.69%5.15%4.14%P/E RatioN/A4.54113.7615.14Price / SalesN/A41.611,483.0493.53Price / CashN/A16.3539.7134.04Price / Book0.183.164.665.01Net Income-$4M$29.98M$119.06M$225.46M7 Day Performance-20.60%-3.56%0.79%0.37%1 Month Performance-8.28%-0.60%5.65%3.57%1 Year Performance-88.78%-2.99%36.80%29.42% MyMD Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MYMDMyMD PharmaceuticalsN/A$1.33-6.3%N/A-87.7%$3.15MN/A0.009FREQFrequency TherapeuticsN/A$0.30flatN/A+20.8%$10.94M$14.07M-0.1646News CoverageGap DownWENAANEW MedicalN/A$0.73-0.5%N/AN/A$12.51MN/A0.00N/AGap UpSNSESensei Biotherapeutics4.3577 of 5 stars$0.49+4.3%$4.33+784.2%-40.2%$12.33MN/A-0.4240Upcoming EarningsIPAImmunoPrecise Antibodies2.5622 of 5 stars$0.42-12.6%$6.00+1,337.1%-80.3%$12.04M$18.16M-0.5480Gap DownAYTUAytu BioPharma1.0503 of 5 stars$1.94+1.0%N/A-28.2%$11.91M$81.00M-0.68160Short Interest ↓Positive NewsGap UpINDPIndaptus Therapeutics3.9478 of 5 stars$1.17flat$12.00+930.0%-49.8%$11.88MN/A-0.636Upcoming EarningsShort Interest ↓Positive NewsTSBXTurnstone Biologics3.6379 of 5 stars$0.50+4.2%$2.13+326.7%-86.0%$11.52M$19.31M-0.1482Positive NewsHigh Trading VolumeADXNAddex Therapeutics1.5096 of 5 stars$10.70+9.7%$30.00+180.4%+62.1%$11.34M$829,941.00-6.5230Gap UpVINCVincerx Pharma3.1332 of 5 stars$0.37+5.8%$2.00+447.9%-59.7%$10.83MN/A-0.2860Gap DownKPRXKiora Pharmaceuticals3.9197 of 5 stars$3.60-0.6%$10.00+177.8%-33.9%$10.69MN/A0.0010Short Interest ↓News CoverageGap Down Related Companies and Tools Related Companies FREQ Alternatives WENA Alternatives SNSE Alternatives IPA Alternatives AYTU Alternatives INDP Alternatives TSBX Alternatives ADXN Alternatives VINC Alternatives KPRX Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MYMD) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MyMD Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MyMD Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MYMD Stock Alerts